Author: Sancricca Cristina
Publisher: Springer Publishing Company
ISSN: 1590-1874
Source: Neurological Sciences, Vol.32, Iss.5, 2011-10, pp. : 841-847
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Update on sporadic inclusion body myositis
Brain, Vol. 134, Iss. 11, 2011-11 ,pp. :
Acta Neuropathologica, Vol. 118, Iss. 3, 2009-09 ,pp. :
Increased plasma amyloid-β 42 protein in sporadic inclusion body myositis
By Abdo Wilson
Acta Neuropathologica, Vol. 118, Iss. 3, 2009-09 ,pp. :
Long-term observational study of sporadic inclusion body myositis
Brain, Vol. 134, Iss. 11, 2011-11 ,pp. :
Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis
Brain, Vol. 132, Iss. 6, 2009-06 ,pp. :